Contec Medical Systems Co Ltd - Asset Resilience Ratio
Contec Medical Systems Co Ltd (300869) has an Asset Resilience Ratio of 22.69% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Contec Medical Systems Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how Contec Medical Systems Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 300869 asset base.
Liquid Assets Composition Over Time
This chart breaks down Contec Medical Systems Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 300869 total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥633.33 Million | 22.69% |
| Total Liquid Assets | CN¥633.33 Million | 22.69% |
Asset Resilience Insights
- Good Liquidity Position: Contec Medical Systems Co Ltd maintains a healthy 22.69% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Contec Medical Systems Co Ltd Industry Peers by Asset Resilience Ratio
Compare Contec Medical Systems Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for Contec Medical Systems Co Ltd (2021–2024)
The table below shows the annual Asset Resilience Ratio data for Contec Medical Systems Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 6.30% | CN¥171.59 Million ≈ $25.11 Million |
CN¥2.73 Billion ≈ $398.83 Million |
-14.00pp |
| 2023-12-31 | 20.30% | CN¥652.02 Million ≈ $95.41 Million |
CN¥3.21 Billion ≈ $470.01 Million |
+19.05pp |
| 2022-12-31 | 1.25% | CN¥46.64 Million ≈ $6.82 Million |
CN¥3.73 Billion ≈ $546.23 Million |
-5.56pp |
| 2021-12-31 | 6.81% | CN¥189.98 Million ≈ $27.80 Million |
CN¥2.79 Billion ≈ $408.12 Million |
-- |
About Contec Medical Systems Co Ltd
Contec Medical Systems Co.,Ltd engages in the research and development, production, and sale of medical diagnosis and monitoring equipment in China and internationally. The company offers electronic sphygmomanometers, ambulatory blood pressure monitors, pulse oximeters, patient monitors, stethoscopes, simulators, multi-parameter vital signs monitors, central monitoring systems, electrocardiograph… Read more